<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35571554</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2233-8276</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Asia Pacific allergy</Title><ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation></Journal><ArticleTitle>Coronavirus disease 2019 (COVID-19) and Long COVID.</ArticleTitle><Pagination><StartPage>e22</StartPage><MedlinePgn>e22</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2022.12.e22</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yoon-Seok</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0003-3157-0447</Identifier><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Asia Pac Allergy</MedlineTA><NlmUniqueID>101561954</NlmUniqueID><ISSNLinking>2233-8276</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35571554</ArticleId><ArticleId IdType="pmc">PMC9066082</ArticleId><ArticleId IdType="doi">10.5415/apallergy.2022.12.e22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cabanillas B, Novak N. Allergy to COVID-19 vaccines: a current update. Allergol Int. 2021;70:313&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062405</ArticleId><ArticleId IdType="pubmed">33962863</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E, Jin J, Park SY, Yoo YS, Lee JH, An J, Song WJ, Kwon HS, Cho YS, Moon HB, Lee JB, Kim TB. Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019. Asia Pac Allergy. 2022;12:e21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066077</ArticleId><ArticleId IdType="pubmed">35571550</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS. Long-term effects of coronavirus (long COVID) [Internet] London: NHS; 2022. Apr 14,  [cited 2022 Apr 27].  Available from:  https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/</Citation></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, Dinh-Xuan AT, Poletti V, Sverzellati N, Vitacca M, Witzenrath M, Tonia T, Spanevello A. European Respiratory Society Statement on Long COVID-19 Follow-Up. Eur Respir J. 2022 Feb 10;:2102174. doi: 10.1183/13993003.02174-2021. [Epub]</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, Comberiati P, Apfelbacher C, Genuneit J, Avdeev S, Kapustina V, Guekht A, Fomin V, Svistunov AA, Timashev P, Subbot VS, Royuk VV, Drake TM, Hanson SW, Merson L, Carson G, Horby P, Sigfrid L, Scott JT, Semple MG, Warner JO, Vos T, Olliaro P, Glybochko P, Butnaru D Sechenov StopCOVID Research Team. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51:1107&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang YR, Oh JY, Lee JH, Small PM, Chung KF, Song WJ. Long-COVID severe refractory cough: discussion of a case with 6-week longitudinal cough characterization. Asia Pac Allergy. 2022;12:e19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066079</ArticleId><ArticleId IdType="pubmed">35571551</ArticleId></ArticleIdList></Reference><Reference><Citation>Batubara IS, Budianti WK. Erythrodermic psoriasis in post-coronavirus disease 2019 patient. Asia Pac Allergy. 2022;12:e16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066080</ArticleId><ArticleId IdType="pubmed">35571549</ArticleId></ArticleIdList></Reference><Reference><Citation>Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386:157&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">35020986</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama H, Kanemitsu Y, Fukumitsu K, Takeda N, Kurokawa R, Tajiri T, Ito K, Yap JMG, Fukuda S, Uemura T, Ohkubo H, Maeno K, Ito Y, Oguri T, Takemura M, Niimi A. Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty. Asia Pac Allergy. 2022;12:e13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066086</ArticleId><ArticleId IdType="pubmed">35571548</ArticleId></ArticleIdList></Reference><Reference><Citation>Motomura C, Okabe K, Matsuzaki H, Kawano T, Akamine Y, Yasunari D, Wakatsuki M, Taba N, Honjo S, Odajima H. Changes in clinical features of food-related anaphylaxis in children during 5 years. Asia Pac Allergy. 2022;12:e14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066084</ArticleId><ArticleId IdType="pubmed">35571556</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo HW, Kim HY, Shin K, Kim SH. Clinical characteristics of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a single-center study. Asia Pac Allergy. 2022;12:e17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066085</ArticleId><ArticleId IdType="pubmed">35571552</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha IM, Gouveia J, Gomes E. Association between self-reported drug hypersensitivity reactions and psychological disorders. Asia Pac Allergy. 2022;12:e15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066087</ArticleId><ArticleId IdType="pubmed">35571546</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>